Which of the following should be reviewed and evaluated by qualified experts to assess implications...

Qualified experts should evaluate emerging animal toxicological and clinical data to assess potential safety implications for trial subjects. These data are critical in identifying potential risks, adverse effects, or safety concerns before exposing human subjects to the investigational product. Early detection of safety issues through expert evaluation helps protect participant well-being.

GCP guidelines stress the importance of expert assessment of preclinical and clinical data to identify risks and ensure participant safety.

"Emerging toxicological and clinical data should be carefully reviewed by qualified experts to identify safety concerns before clinical use."

Objectives:

Ensure participant safety through expert data analysis.

Identify potential safety risks early in the trial process.